Curis, Inc.

Good morning, ladies and gentlemen, and welcome to the Curious Provides first quarter 2025 business update conference call. At this time, all lines are in listen-only mode. Following the presentation, we'll conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, May 6, 2025. I would now like to turn the conference over to Diantha Duvall. Please go ahead.

Thank you, and welcome to the QRIS first quarter 2025 business update call. Before we begin, I would like to encourage everyone to go to the investor section of our website at www.qris.com to find our first quarter 2025 business update press release and related financial tables. I would also like to remind everyone that during the call, we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and actual results may differ materially. For additional details, please see our SEC filings. Joining me on today's call are Jim Denser, President and Chief Executive Officer, Jonathan Zung, Chief Development Officer, and Dr. Ahmed Hamdi, joining us today as our new chief medical officer. We will also be available for a question and answer period at the end of the call. I'd now like to turn the call over to Jim.

Thanks, Dantha. Good morning, everyone, and welcome to QRIS's first quarter business update call. I'd like to start this quarter's call by welcoming Dr. Ahmed Hamdi to the QRIS executive team. Dr. Hamdi is a well-known and respected leader in the industry and brings a wealth of experience, as the CMO of Pharmacyclics, founder and CMO of Asserta, and founder and CEO of VinceRx. Achmed, welcome.